Join our new #UROwebinar! 3 presentations on real-world cases, innovative approaches, & expert recommendations in stone treatment provided by experts @oangerri, @drmarcoscepeda, @wojciechpiotrk1, & @dperfen. Register now and claim your CME credit 👉 https://t.co/9NOKrIXTZT

Many thanks to my hosts @wojciechpiotrk1 @bartmalkiewicz Jan Łaszkiewicz and the rest of the wonderful Dept of Urology at Wroclaw Medical University observed really cutting edge Endourology and robotics. Also was interviewed by the local TV station as a highlight to my visit.

Our new SR and MA published in @EurUrolOncol evaluates focal therapy for localized PCa using prospective data only. Important for patient counselling. 📊 50 studies, 4,615 patients 📊 12-mo csPCa RFS in intermediate-risk: 79% (95% CI 74–83%) 🔗 https://t.co/jkiz7WlcRY

Histological subtypes/divergent differentiation (HS/DD) in UTUC = worse outcomes. In a review of 14,407 patients, HS/DD linked to higher stage/grade, more LNI/LVI, and worse CSS, OS, RFS. Detection should prompt aggressive tx + close follow-up. https://t.co/m8QrOGAAda

One week left until the upcoming #eGrandRounds Update in #StoneManagement on #SIUAcademy! Watch skilled surgeons perform #StandardECIRS & #fURS, followed by in-depth post-surgery discussions with renowned faculty. 🗓️ Feb 12, 2025 | 9:00-12:30 CET (UTC+1) 💻 Register early

Honored to become an Associate Member of the YAU Endourology & Urolithiasis Group! Looking forward to exciting new scientific collaborations and advancing research in the field. I am deeply grateful for the invaluable scientific mentorship of @wojciechpiotrk1

📣 Don't miss the first #eGrandRounds of 2025 - Update in #StoneManagement on #SIUAcademy! Watch skilled surgeons perform #MIP and #fURS and listen in as our expert faculty engage in lively post-surgery discussions. Registration is free, enroll today! 🔗 https://t.co/c1NRUXX9Zq

BN145: the exact dates for ICE. Meeting 2025 are: 27-29 NOVEMBER 2025. ROMA-Italy

@OTRAXER Preparations on the way from the EAU Endourology Stone Surgical Team for the best congress of all times #ICE25 😉💪🏻🔥

Gratulacje dla organizatorów 11 Sympozjum Sekcji Urologii Onkologicznej PTU Prof.Roman Sosnowski @dr_rajwa @wojciechpiotrk1 . Świetne spotkanie merytoryczne oraz świetni wykładowcy !! @ArturLeminski @bartmalkiewicz @mslojewski @AAAntoniewicz

20th HoLEP procedure 90 ml Enucleaction + morcellation = 60 min Early apical release Catheter removed 24h after procedure Full continence Full of gratitude to @wojciechpiotrk1 for constant tutoring

Dr @wojciechpiotrk1 will discuss about "Suction during ECIRS : Does it really help?" during @endouroacademy webinar "New game changers in RIRS: How to choose the correct technology." Webinar registration: https://t.co/uv21Z2QfLv supported by @ClearpetraL

Endourology Academy Upcoming Webinar! Join us on Oct 4, 2024 at 2 PM CET for "New Game Changers in RIRS: How to Choose the Correct Technology" supported by @ClearpetraL Registration: https://t.co/uv21Z2QfLv

🤩 Wonderful days in 🇵🇱 with new & old friends at @PTUweb national congress! 🙏 for the great hospitality & see you soon @dr_rajwa @bartmalkiewicz @wojciechpiotrk1 @Uroweb @EAU_Uroonco @EAUYAUrology @EAU_YAUProstate

Great experience to present about bladder sparing strategies in MIBC patients at the national Polish association meeting. Congrats @dr_rajwa and @wojciechpiotrk1 for the great work !

FANS are becoming a standard! Another step forward in providing top-notch care for our patients with urolithiasis! 1550 HU 20 x 17 mm stone removed in 42 min. 11/13 ClearPetra UAS 8.5 Fr Hawk ureteroscope @wojciechpiotrk1 @bartmalkiewicz @ChorbinskaJ

Nice depicting of apical urethra rather than apical mucosa sparing. by cutting the mucosa we also preserve the underlying structures such as #lisso #sphincter. #Urethrasparing @SIU_urology #BPO update Wojciech Krajewski

#HoLEP at #BPO Update @SIU_urology by Wojciech Krajewski @MauroGacci @StavrosGravas @scoffonecesare @SIU_urology Nice

Our latest SR and MA "Clinical and Oncological Outcomes Following Percutaneous Cryoablation vs. Partial Nephrectomy for Clinical T1 Renal Tumours: Systematic Review and Meta-Analysis" is now available. @wojciechpiotrk1 @bartmalkiewicz @ChorbinskaJ @f_delgiudice

Patients with very high-risk non muscle invasive #bladdercancer who receive adequate BCG therapy: ✅ Have a more favorable prognosis than predicted by EAU risk groups, especially among those with a sustained response https://t.co/hbV3HIIgVv @eau_yuo @EAUYAUrology